Shanghai Junshi Biosciences Co (FRA:8SJ) Cash Flow for Dividends: €0.0 Mil (TTM As of Dec. 2025)


FRA:8SJ Shanghai Junshi Biosciences Co Ltd FRA:8SJ
65 GF Score
Price €1.85
GF Value €3.11
! 5 Warning Signs
View Full Analysis

What is Shanghai Junshi Biosciences Co Cash Flow for Dividends?

Shanghai Junshi Biosciences Co FRA:8SJ 65 Cash Flow for Dividends is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:8SJ with a GF Score™ of 65/100 and a GF Value™ of €3.11. The stock has 5 warning signs investors should review.

Shanghai Junshi Biosciences Co's cash flow for dividends for the six months ended in Dec. 2025 was €0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Shanghai Junshi Biosciences Co's annual payment of dividends stayed the same from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil) but then increased from Dec. 2024 (€0.0 Mil) to Dec. 2025 (€-11.4 Mil).

Shanghai Junshi Biosciences Co Cash Flow for Dividends Related Terms

Shanghai Junshi Biosciences Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Shanghai Junshi Biosciences Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Junshi Biosciences Co Cash Flow for Dividends Chart

Shanghai Junshi Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -11.44

Shanghai Junshi Biosciences Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:8SJ
65GF Score
Shanghai Junshi Biosciences Co Ltd FRA:8SJ
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Junshi Biosciences Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €0.0 Mil mean?
Shanghai Junshi Biosciences Co (FRA:8SJ) has a Cash Flow for Dividends of €0.0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shanghai Junshi Biosciences Co and its competitors.
Is Shanghai Junshi Biosciences Co's Cash Flow for Dividends too high?
Shanghai Junshi Biosciences Co's current Cash Flow for Dividends is €0.0 Mil. Overall, Shanghai Junshi Biosciences Co has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Junshi Biosciences Co's Cash Flow for Dividends compare to VRTX and REGN?
Shanghai Junshi Biosciences Co's Cash Flow for Dividends of €0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shanghai Junshi Biosciences Co and its competitors. Shanghai Junshi Biosciences Co's current Cash Flow for Dividends is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Junshi Biosciences Co stock overvalued right now?
Shanghai Junshi Biosciences Co (FRA:8SJ) has a current Cash Flow for Dividends of €0.0 Mil. The stock's GF Value™ is €3.11, compared to a current price of €1.85 — trading 40.5% below its estimated fair value. The current Cash Flow for Dividends is €0.0 Mil. Shanghai Junshi Biosciences Co's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Shanghai Junshi Biosciences Co (FRA:8SJ), the current Cash Flow for Dividends is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Junshi Biosciences Co (FRA:8SJ) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co stock appears to be undervalued. The current stock price of €1.85 is trading 40.5% below its estimated GF Value™ of €3.11.

Key valuation signals for FRA:8SJ:

  • Cash Flow for Dividends: €0.0 Mil
  • GF Value™: €3.11 vs. price of €1.85 (40.5% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the FRA:8SJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Junshi Biosciences Co Business Description

Address No. 987 Cai Lun Road, Level 4, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly involved in the discovery, development, and commercialisation of therapeutic drugs. It focuses on the development and commercialization of several kinds of drugs, ranging from monoclonal antibodies to various drug modalities, including small molecules, ADCs, bi-specific or multi-specific antibodies, fusion proteins, nucleic acid drugs, and vaccines, as well as the exploration of next-generation therapies, including those for cancer and autoimmune diseases. The Group's portfolio includes commercialized drugs such as Tuoyi, Junmaikang, Mindewei, and Junshida, as well as products in clinical studies or in the marketing application stage. Geographically, it derives maximum revenue from Mainland China, and the rest from USA, India, and other markets.
65GF Score

Get the complete analysis for FRA:8SJ

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.85
Price
€3.11
GF Value